54 related articles for article (PubMed ID: 32155529)
1. Discovery of pyrazole derivatives as cellular active inhibitors of histone lysine specific demethylase 5B (KDM5B/JARID1B).
Zhao B; Liang Q; Ren H; Zhang X; Wu Y; Zhang K; Ma LY; Zheng YC; Liu HM
Eur J Med Chem; 2020 Apr; 192():112161. PubMed ID: 32155529
[TBL] [Abstract][Full Text] [Related]
2. Discovery of an efficacious KDM5B PROTAC degrader GT-653 up-regulating IFN response genes in prostate cancer.
Guan T; Zhang Y; Li S; Zhang W; Song Y; Li Y; He Y; Chen Y
Eur J Med Chem; 2024 Jun; 272():116494. PubMed ID: 38749268
[TBL] [Abstract][Full Text] [Related]
3. Lysine demethylase 5B (KDM5B): A key regulator of cancer drug resistance.
Cao Y; Wu C; Ma L
J Biochem Mol Toxicol; 2024 Jan; 38(1):e23587. PubMed ID: 38014925
[TBL] [Abstract][Full Text] [Related]
4. Discovery and Optimization of Potent, Cell-Active Pyrazole-Based Inhibitors of Lactate Dehydrogenase (LDH).
Rai G; Brimacombe KR; Mott BT; Urban DJ; Hu X; Yang SM; Lee TD; Cheff DM; Kouznetsova J; Benavides GA; Pohida K; Kuenstner EJ; Luci DK; Lukacs CM; Davies DR; Dranow DM; Zhu H; Sulikowski G; Moore WJ; Stott GM; Flint AJ; Hall MD; Darley-Usmar VM; Neckers LM; Dang CV; Waterson AG; Simeonov A; Jadhav A; Maloney DJ
J Med Chem; 2017 Nov; 60(22):9184-9204. PubMed ID: 29120638
[TBL] [Abstract][Full Text] [Related]
5. Discovery of a Highly Selective Cell-Active Inhibitor of the Histone Lysine Demethylases KDM2/7.
Gerken PA; Wolstenhulme JR; Tumber A; Hatch SB; Zhang Y; Müller S; Chandler SA; Mair B; Li F; Nijman SMB; Konietzny R; Szommer T; Yapp C; Fedorov O; Benesch JLP; Vedadi M; Kessler BM; Kawamura A; Brennan PE; Smith MD
Angew Chem Int Ed Engl; 2017 Dec; 56(49):15555-15559. PubMed ID: 28976073
[TBL] [Abstract][Full Text] [Related]
6. Histone demethylase KDM5B licenses macrophage-mediated inflammatory responses by repressing Nfkbia transcription.
Zhang Y; Gao Y; Jiang Y; Ding Y; Chen H; Xiang Y; Zhan Z; Liu X
Cell Death Differ; 2023 May; 30(5):1279-1292. PubMed ID: 36914768
[TBL] [Abstract][Full Text] [Related]
7. KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid accumulation in pancreatic ductal adenocarcinoma.
Wang Y; Liu S; Wang Y; Li B; Liang J; Chen Y; Tang B; Yu S; Wang H
Cell Death Discov; 2024 May; 10(1):252. PubMed ID: 38789418
[TBL] [Abstract][Full Text] [Related]
8. Structure and binding properties of a cameloid nanobody raised against KDM5B.
Wiuf A; Kristensen LH; Kristensen O; Dorosz J; Jensen J; Gajhede M
Acta Crystallogr F Struct Biol Commun; 2015 Oct; 71(Pt 10):1235-41. PubMed ID: 26457512
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of KDM5B participates in immune microenvironment remodeling in pancreatic cancer by inducing STING expression.
Li X; Li J; Liu Y; Sun L; Tai Q; Gao S; Jiang W
Cytokine; 2024 Mar; 175():156451. PubMed ID: 38163400
[TBL] [Abstract][Full Text] [Related]
10. Jumonji/Arid1b (Jarid1b) protein modulates human esophageal cancer cell growth.
Kano Y; Konno M; Ohta K; Haraguchi N; Nishikawa S; Kagawa Y; Hamabe A; Hasegawa S; Ogawa H; Fukusumi T; Noguchi Y; Ozaki M; Kudo T; Sakai D; Satoh T; Ishii M; Mizohata E; Inoue T; Mori M; Doki Y; Ishii H
Mol Clin Oncol; 2013 Jul; 1(4):753-757. PubMed ID: 24649241
[TBL] [Abstract][Full Text] [Related]
11. Persister state-directed transitioning and vulnerability in melanoma.
Chauvistré H; Shannan B; Daignault-Mill SM; Ju RJ; Picard D; Egetemaier S; Váraljai R; Gibhardt CS; Sechi A; Kaschani F; Keminer O; Stehbens SJ; Liu Q; Yin X; Jeyakumar K; Vogel FCE; Krepler C; Rebecca VW; Kubat L; Lueong SS; Forster J; Horn S; Remke M; Ehrmann M; Paschen A; Becker JC; Helfrich I; Rauh D; Kaiser M; Gul S; Herlyn M; Bogeski I; Rodríguez-López JN; Haass NK; Schadendorf D; Roesch A
Nat Commun; 2022 Jun; 13(1):3055. PubMed ID: 35650266
[TBL] [Abstract][Full Text] [Related]
12. Exploration of 5-cyano-6-phenylpyrimidin derivatives containing an 1,2,3-triazole moiety as potent FAD-based LSD1 inhibitors.
Ma L; Wang H; You Y; Ma C; Liu Y; Yang F; Zheng Y; Liu H
Acta Pharm Sin B; 2020 Sep; 10(9):1658-1668. PubMed ID: 33088686
[TBL] [Abstract][Full Text] [Related]
13. LSD1 deletion represses gastric cancer migration by upregulating a novel miR-142-5p target protein CD9.
Zhao LJ; Fan QQ; Li YY; Ren HM; Zhang T; Liu S; Maa M; Zheng YC; Liu HM
Pharmacol Res; 2020 Sep; 159():104991. PubMed ID: 32504836
[TBL] [Abstract][Full Text] [Related]
14. Tranylcypromine Based Lysine-Specific Demethylase 1 Inhibitor: Summary and Perspective.
Dai XJ; Liu Y; Xiong XP; Xue LP; Zheng YC; Liu HM
J Med Chem; 2020 Dec; 63(23):14197-14215. PubMed ID: 32931269
[TBL] [Abstract][Full Text] [Related]
15. Chemical molecular-based approach to overcome multidrug resistance in cancer by targeting P-glycoprotein (P-gp).
Zhang H; Xu H; Ashby CR; Assaraf YG; Chen ZS; Liu HM
Med Res Rev; 2021 Jan; 41(1):525-555. PubMed ID: 33047304
[TBL] [Abstract][Full Text] [Related]
16. Down-Regulation of USP8 Suppresses HER-3 Positive Gastric Cancer Cells Proliferation.
Sun J; Shen D; Gao Y; Zheng Y; Zhao L; Maa M; Liu H; Chen X
Onco Targets Ther; 2020; 13():7973-7984. PubMed ID: 32848421
[TBL] [Abstract][Full Text] [Related]
17. Skp2 in the ubiquitin-proteasome system: A comprehensive review.
Asmamaw MD; Liu Y; Zheng YC; Shi XJ; Liu HM
Med Res Rev; 2020 Sep; 40(5):1920-1949. PubMed ID: 32391596
[TBL] [Abstract][Full Text] [Related]
18. KDM5B Is Essential for the Hyperactivation of PI3K/AKT Signaling in Prostate Tumorigenesis.
Li G; Kanagasabai T; Lu W; Zou MR; Zhang SM; Celada SI; Izban MG; Liu Q; Lu T; Ballard BR; Zhou X; Adunyah SE; Matusik RJ; Yan Q; Chen Z
Cancer Res; 2020 Nov; 80(21):4633-4643. PubMed ID: 32868382
[TBL] [Abstract][Full Text] [Related]
19. Discovery of new [1,2,4] Triazolo[1,5-a]Pyrimidine derivatives that Kill gastric cancer cells via the mitochondria pathway.
Wang S; Ma XB; Yuan XH; Yu B; Xu YC; Liu HM
Eur J Med Chem; 2020 Oct; 203():112630. PubMed ID: 32683165
[TBL] [Abstract][Full Text] [Related]
20. Correction: JARID1B promotes metastasis and epithelial-mesenchymal transition via PTEN/AKT signaling in hepatocellular carcinoma cells.
Tang B; Qi G; Tang F; Yuan S; Wang Z; Liang X; Li B; Yu S; Liu J; Huang Q; Wei Y; Zhai R; Lei B; Yu H; Jiao X; He S
Oncotarget; 2020 May; 11(19):1797-1798. PubMed ID: 32477467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
